| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Biochemistry and Molecular Biology, College of Pharmacy [J-W. H., S. H. A., S. H. P., S. Y. W., G-U. B., D-W. S., H-K. K., H-W. L.], and Department of Genetic Engineering, College of Life Science and Natural Resources [S. H.], Sungkyunkwan University, Suwon 440-746; Department of Pharmacology, College of Medicine, Konyang University, Nonsan 320-711 [H. Y. L.]; and School of Agricultural Biotechnology, Seoul National University, Suwon 441-744 [Y-W. L.], Korea
Apicidin [cyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl)] is a fungal metabolite shown to exhibit antiparasitic activity by the inhibition of histone deacetylase (HDAC). In this study, we evaluated apicidin as a potential antiproliferative agent. Apicidin showed a broad spectrum of antiproliferative activity against various cancer cell lines, although with differential sensitivity. The antiproliferative activity of apicidin on HeLa cells was accompanied by morphological changes, cell cycle arrest at G1 phase, and accumulation of hyperacetylated histone H4 in vivo as well as inhibition of partially purified HDAC in vitro. In addition, apicidin induced selective changes in the expression of p21WAF1/Cip1 and gelsolin, which control the cell cycle and cell morphology, respectively. Consistent with increased induction of p21WAF1/Cip1, phosphorylation of Rb protein was markedly decreased, indicating the inhibition of cyclin-dependent kinases, which became bound to p21WAF1/Cip1. The effects of apicidin on cell morphology, expression of gelsolin, and HDAC1 activity in vivo and in vitro appeared to be irreversible, because withdrawal of apicidin did not reverse those effects, whereas the induction of p21WAF1/Cip1 by apicidin was reversible. Taken together, the results suggest that induction of histone hyperacetylation by apicidin is responsible for the antiproliferative activity through selective induction of genes that play important roles in the cell cycle and cell morphology.
This article has been cited by other articles:
|
|
 |
|
  J. S. You, J. K. Kang, D.-W. Seo, J. H. Park, J. W. Park, J. C. Lee, Y. J. Jeon, E. J. Cho, and J.-W. Han Depletion of Embryonic Stem Cell Signature by Histone Deacetylase Inhibitor in NCCIT Cells: Involvement of Nanog Suppression Cancer Res., July 15, 2009; 69(14): 5716 - 5725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-N. Kim, N. H. Kim, W. Lee, D.-W. Seo, and Y. K. Kim Histone Deacetylase Inhibitor Induction of P-Glycoprotein Transcription Requires Both Histone Deacetylase 1 Dissociation and Recruitment of CAAT/Enhancer Binding Protein {beta} and pCAF to the Promoter Region Mol. Cancer Res., May 1, 2009; 7(5): 735 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lin, J.-H. Lin, C.-W. Chou, Y.-F. Chang, S.-H. Yeh, and C.-C. Chen Statins Increase p21 through Inhibition of Histone Deacetylase Activity and Release of Promoter-Associated HDAC1/2 Cancer Res., April 1, 2008; 68(7): 2375 - 2383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Di Renzo, M. L. Broccia, E. Giavini, and E. Menegola Relationship between Embryonic Histonic Hyperacetylation and Axial Skeletal Defects in Mouse Exposed to the Three HDAC Inhibitors Apicidin, MS-275, and Sodium Butyrate Toxicol. Sci., August 1, 2007; 98(2): 582 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Archer, J. Johnson, H.-J. Kim, Q. Ma, H. Mou, V. Daesety, S. Meng, and R. A. Hodin The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G696 - G703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Acharya, A. Sparreboom, J. Venitz, and W. D. Figg Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review Mol. Pharmacol., October 1, 2005; 68(4): 917 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Bhalla Epigenetic and Chromatin Modifiers As Targeted Therapy of Hematologic Malignancies J. Clin. Oncol., June 10, 2005; 23(17): 3971 - 3993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Varshochi, F. Halim, A. Sunters, J. P. Alao, P. A. Madureira, S. M. Hart, S. Ali, D. M. Vigushin, R. C. Coombes, and E. W.-F. Lam ICI182,780 Induces p21Waf1 Gene Transcription through Releasing Histone Deacetylase 1 and Estrogen Receptor {alpha} from Sp1 Sites to Induce Cell Cycle Arrest in MCF-7 Breast Cancer Cell Line J. Biol. Chem., February 4, 2005; 280(5): 3185 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hu and N. H. Colburn Histone Deacetylase Inhibition Down-Regulates Cyclin D1 Transcription by Inhibiting Nuclear Factor-{kappa}B/p65 DNA Binding Mol. Cancer Res., February 1, 2005; 3(2): 100 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Kim, J.-W. Park, J.-Y. Lee, and T. K. Kwon Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells Carcinogenesis, October 1, 2004; 25(10): 1813 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Park, Y. Jung, T. Y. Kim, S. G. Kim, H.-S. Jong, J. W. Lee, D.-K. Kim, J.-S. Lee, N. K. Kim, T.-Y. Kim, et al. Class I Histone Deacetylase-Selective Novel Synthetic Inhibitors Potently Inhibit Human Tumor Proliferation Clin. Cancer Res., August 1, 2004; 10(15): 5271 - 5281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Maggio, R. R. Rosato, L. B. Kramer, Y. Dai, M. Rahmani, D. S. Paik, A. C. Czarnik, S. G. Payne, S. Spiegel, and S. Grant The Histone Deacetylase Inhibitor MS-275 Interacts Synergistically with Fludarabine to Induce Apoptosis in Human Leukemia Cells Cancer Res., April 1, 2004; 64(7): 2590 - 2600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Rosato, J. A. Almenara, C. Yu, and S. Grant Evidence of a Functional Role for p21WAF1/CIP1 Down-Regulation in Synergistic Antileukemic Interactions between the Histone Deacetylase Inhibitor Sodium Butyrate and Flavopiridol Mol. Pharmacol., March 1, 2004; 65(3): 571 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Atadja, L. Gao, P. Kwon, N. Trogani, H. Walker, M. Hsu, L. Yeleswarapu, N. Chandramouli, L. Perez, R. Versace, et al. Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824 Cancer Res., January 15, 2004; 64(2): 689 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Cheong, S. Y. Chong, J. Y. Kim, J. I. Eom, H. K. Jeung, H. Y. Maeng, S. T. Lee, and Y. H. Min Induction of Apoptosis by Apicidin, a Histone Deacetylase Inhibitor, via the Activation of Mitochondria-Dependent Caspase Cascades in Human Bcr-Abl-Positive Leukemia Cells Clin. Cancer Res., October 15, 2003; 9(13): 5018 - 5027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Di Padova, T. Bruno, F. De Nicola, S. Iezzi, C. D'Angelo, R. Gallo, D. Nicosia, N. Corbi, A. Biroccio, A. Floridi, et al. Che-1 Arrests Human Colon Carcinoma Cell Proliferation by Displacing HDAC1 from the p21WAF1/CIP1 Promoter J. Biol. Chem., September 19, 2003; 278(38): 36496 - 36504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Rosato, J. A. Almenara, and S. Grant The Histone Deacetylase Inhibitor MS-275 Promotes Differentiation or Apoptosis in Human Leukemia Cells through a Process Regulated by Generation of Reactive Oxygen Species and Induction of p21CIP1/WAF1 1 Cancer Res., July 1, 2003; 63(13): 3637 - 3645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lagger, A. Doetzlhofer, B. Schuettengruber, E. Haidweger, E. Simboeck, J. Tischler, S. Chiocca, G. Suske, H. Rotheneder, E. Wintersberger, et al. The Tumor Suppressor p53 and Histone Deacetylase 1 Are Antagonistic Regulators of the Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1 Gene Mol. Cell. Biol., April 15, 2003; 23(8): 2669 - 2679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Witt, S. Monkemeyer, G. Ronndahl, B. Erdlenbruch, D. Reinhardt, K. Kanbach, and A. Pekrun Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin Blood, March 1, 2003; 101(5): 2001 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fournel, M.-C. Trachy-Bourget, P. T. Yan, A. Kalita, C. Bonfils, C. Beaulieu, S. Frechette, S. Leit, E. Abou-Khalil, S.-H. Woo, et al. Sulfonamide Anilides, a Novel Class of Histone Deacetylase Inhibitors, Are Antiproliferative against Human Tumors Cancer Res., August 1, 2002; 62(15): 4325 - 4330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Taniura, H. Kamitani, T. Watanabe, and T. E. Eling Transcriptional Regulation of Cyclooxygenase-1 by Histone Deacetylase Inhibitors in Normal Human Astrocyte Cells J. Biol. Chem., May 3, 2002; 277(19): 16823 - 16830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tsubaki, V. Hwa, S. M. Twigg, and R. G. Rosenfeld Differential Activation of the IGF Binding Protein-3 Promoter by Butyrate in Prostate Cancer Cells Endocrinology, May 1, 2002; 143(5): 1778 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kamitani, S. Taniura, K. Watanabe, M. Sakamoto, T. Watanabe, and T. Eling Histone acetylation may suppress human glioma cell proliferation when p21WAF/Cip1 and gelsolin are induced Neuro-oncol, April 1, 2002; 4(2): 95 - 101. [Abstract] [PDF]
|
|
|
|
|
|
J.-W. Han, S. H. Ahn, Y. K. Kim, G.-U. Bae, J. W. Yoon, S. Hong, H. Y. Lee, Y.-W. Lee, and H.-W. Lee Activation of p21WAF1/Cip1 Transcription through Sp1 Sites by Histone Deacetylase Inhibitor Apicidin. INVOLVEMENT OF PROTEIN KINASE C J. Biol. Chem., November 2, 2001; 276(45): 42084 - 42090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Kwon, S. H. Ahn, Y. K. Kim, G.-U. Bae, J. W. Yoon, S. Hong, H. Y. Lee, Y.-W. Lee, H.-W. Lee, and J.-W. Han Apicidin, a Histone Deacetylase Inhibitor, Induces Apoptosis and Fas/Fas Ligand Expression in Human Acute Promyelocytic Leukemia Cells J. Biol. Chem., January 11, 2002; 277(3): 2073 - 2080. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
